Levetiracetam — Dosing in CKD & Dialysis

Levetiracetam (Anticonvulsant): renal dosing adjustments, dialyzability (Moderate (about 50% removed in a standard 4-hour hemodialysis)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.